Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-04-10
1987-04-28
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 530326, C07K 708, A61K 3702
Patent
active
046614710
ABSTRACT:
A method of inhibiting thrombin or ADP-induced human platelet aggregation by fibrinogen has been developed. The administration of the small molecular weight peptide or the synthetic inhibitory molecule of the invention significantly inhibits thrombin or ADP-modified human platelets binding of fibrinogen, a plasma protein necessary for platelet aggregation. The method of the invention is useful for inhibiting of the formation of hemostatic platelet plugs and of the initiation of thrombotic lesions. The blockage caused by hemostatic platelet plugs and the damage caused by thrombotic lesions are major factors in heart disease and stroke. The invention also includes a method of inducing the formation of thrombin or ADP-modified platelet aggregates by administration of a synthetic aggregating molecule which represents a functional substitute for fibrinogen.
REFERENCES:
patent: 4303592 (1981-12-01), Laura et al.
patent: 4351337 (1982-09-01), Sidman
patent: 4455290 (1984-06-01), Olepa et al.
patent: 4476116 (1984-10-01), Anik
"Localization of a Fibrin .alpha.-Chain Polymerization Site within Segment Thr-374 to Glu-396 of Human Fibrinogen" Proc. Natl. Ac. Sci., (USA), 81, pp. 5980-5984 (1984).
Biochemistry, 1982, vol. 21, No. 6, pp. 1414-1420-Isolation, Characterization and Synthesis of Peptides from Human Fibrinogen that Block the Staphylococcal Clumping Reaction and Construction of a Synthetic Particle.
Biochemical and Biophysical Research Communications, vol. 107, No. 1, Jul. 16, 1982, pp. 181-187-Localization of a Site Interacting with Human Platelet Receptor on Carboxy-Terminal Segment of Human Fibrinogen Chain.
Thrombosis Research 29; 249-255, 1983--Fibrinogen Site for Platelets.
Hawiger Jack J.
Kloczewiak Marek
Lukas Thomas J.
Timmons Sheila
New England Deaconess Hospital
Phillips Delbert R.
LandOfFree
Method of inhibiting and inducing human platelet aggregation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting and inducing human platelet aggregation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting and inducing human platelet aggregation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-477362